Duality Advisers, LP Agios Pharmaceuticals, Inc. Transaction History

Duality Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 27, 2023	BUY	$21.74 - $30.93 $536,086 - $762,702	24,659 New	24,659 $566,000
Q1 2022 May 09, 2022	SELL	$26.68 - $34.81 $1.45 Million - $1.9 Million	-54,530 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$29.58 - $49.78 $1.61 Million - $2.71 Million	54,530 New	54,530 $1.79 Million
Q3 2021 Nov 08, 2021	SELL	$41.92 - $58.18 $980,089 - $1.36 Million	-23,380 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$52.06 - $61.27 $1.22 Million - $1.43 Million	23,380 New	23,380 $1.29 Million
Q4 2020 Feb 09, 2021	SELL	$33.21 - $46.54 $1.14 Million - $1.6 Million	-34,290 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$33.87 - $55.93 $1.16 Million - $1.92 Million	34,290 New	34,290 $1.2 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.